Cancer stem cells in hepatocellular carcinoma — from origin to clinical implications

Terence Kin Wah Lee, Xin Yuan Guan, Stephanie Ma

Research output: Journal article publicationReview articleAcademic researchpeer-review

10 Citations (Scopus)

Abstract

Hepatocellular carcinoma (HCC) is an aggressive disease with a poor clinical outcome. The cancer stem cell (CSC) model states that tumour growth is powered by a subset of tumour stem cells within cancers. This model explains several clinical observations in HCC (as well as in other cancers), including the almost inevitable recurrence of tumours after initial successful chemotherapy and/or radiotherapy, as well as the phenomena of tumour dormancy and treatment resistance. The past two decades have seen a marked increase in research on the identification and characterization of liver CSCs, which has encouraged the design of novel diagnostic and treatment strategies for HCC. These studies revealed novel aspects of liver CSCs, including their heterogeneity and unique immunobiology, which are suggestive of opportunities for new research directions and potential therapies. In this Review, we summarize the present knowledge of liver CSC markers and the regulators of stemness in HCC. We also comprehensively describe developments in the liver CSC field with emphasis on experiments utilizing single-cell transcriptomics to understand liver CSC heterogeneity, lineage-tracing and cell-ablation studies of liver CSCs, and the influence of the CSC niche and tumour microenvironment on liver cancer stemness, including interactions between CSCs and the immune system. We also discuss the potential application of liver CSC-based therapies for treatment of HCC.

Original languageEnglish
Pages (from-to)26-44
Number of pages19
JournalNature Reviews Gastroenterology and Hepatology
Volume19
Issue number1
DOIs
Publication statusPublished - Jan 2022

ASJC Scopus subject areas

  • Hepatology
  • Gastroenterology

Cite this